MeSH tree: D23.050.705.230.544
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The device identifies the biomarker molecule CA19-9, which is associated with the disease, at low concentrations ...
14 hours ago
0
2
A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma (PDAC) compared to measuring ...
Jan 28, 2026
0
11
Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools. While the traditional staging systems, such as the TNM classification, focus on anatomical ...
Dec 13, 2025
0
13
Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 (NRG1)-positive cholangiocarcinoma, ...
Oct 22, 2025
0
15
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American Association for Cancer Research ...
Apr 8, 2024
0
55
A blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.
Apr 8, 2024
0
56
Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test ...
Jan 22, 2024
0
91
In a significant breakthrough that could eventually extend the survival of patients with one of the deadliest of all malignancies, an international team of researchers have devised an investigational blood test that might ...
Oct 19, 2023
0
52
Tiny packets of molecular cargo shed by cancer cells seed the foundations for metastasis at distant sites in the body.
Jun 19, 2023
0
61
Finding cancer quickly is key in securing the best possible outcome for the patient.
Jun 5, 2023
0
39
